Background/Aim. Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) 2019 infection represents a global problem. At this moment, in October 2020, there is no vaccine or efficient treatment for infected patients. Treatment with blood plasma rich anti-SARS-CoV-2 specific antibodies might be safe, and effective therapy COVID-19 Methods. A total of 768 patients were analyzed study, whose s...

Background: SARS-COV2 (Covid19) pandemic has a scaring burden on hospitals and health care providers all over the world. Unfortunately, after one year of pandemic, millions persons are infected either mild symptoms or critical ones unexplained deaths. Till now, No effective treatment vaccination. Researches showed that Covid 19 associated with elevated interleukin-6. Subsequently, Studies repor...

Since the beginning of SARS-CoV-2(severe acute respiratory syndrome-coronavirus-2) pandemic, a race to develop vaccine has been initiated, considering massive and rather significant economic healthcare hits that this virus caused. The pathophysiology occurring following COVID-19(coronavirus disease-2019) infection given hints regarding supportive symptomatic treatments establish for patients, a...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of COVID-19, which has affected international healthcare systems since beginning 2020. Among sanitizing approaches, UV irradiation a well-known technology often used in different environments to reduce microbial contamination and viral transmission. In particular, several works have demonstrated that UVC radiati...

O novo Coronavírus (COVID-19) constitui uma Emergência de Saúde Pública Importância Internacional – o mais alto nível alerta da Organização Mundial Saúde. Os profissionais enfermagem têm enfrentado rotineiramente precarização no processo trabalho e inúmeros problemas sistema saúde. objetivo desse estudo foi analisar as evidências das publicações científicas acerca dos desafios frente à pandemia...